These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17219235)

  • 1. Restricted diffusion in Canavan disease.
    Srikanth SG; Chandrashekar HS; Nagarajan K; Jayakumar PN
    Childs Nerv Syst; 2007 Apr; 23(4):465-8. PubMed ID: 17219235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI.
    Janson CG; McPhee SW; Francis J; Shera D; Assadi M; Freese A; Hurh P; Haselgrove J; Wang DJ; Bilaniuk L; Leone P
    Neuropediatrics; 2006 Aug; 37(4):209-21. PubMed ID: 17177147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of localized proton nuclear magnetic resonance spectroscopy in Canavan's disease.
    Aydinli N; Calişkan M; Calay M; Ozmen M
    Turk J Pediatr; 1998; 40(4):549-57. PubMed ID: 10028864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Canavan disease or N-acetyl aspartic aciduria: a case report].
    Boughamoura L; Chaabane F; Tilouche S; Chabchoub I; Kabachi N; Tlili K; Yacoub M; Essoussi AS
    Arch Pediatr; 2007 Feb; 14(2):173-6. PubMed ID: 17196380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An atypical case of Canavan disease with stroke-like presentation.
    Delaney KE; Kralik SF; Hainline BE; Golomb MR
    Pediatr Neurol; 2015 Feb; 52(2):218-21. PubMed ID: 25497124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging in juvenile Canavan disease.
    Toft PB; Geiss-Holtorff R; Rolland MO; Pryds O; Müller-Forell W; Christensen E; Lehnert W; Lou HC; Ott D; Hennig J
    Eur J Pediatr; 1993 Sep; 152(9):750-3. PubMed ID: 8223809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Megalencephaly with dystonia revealing Canavan disease].
    Maaloul I; Fourati H; Wali M; Chabchoub I; Kamoun T; Mnif Z; Kaabachi N; Hachicha M
    Arch Pediatr; 2013 Jul; 20(7):783-6. PubMed ID: 23727372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.
    Francis JS; Wojtas I; Markov V; Gray SJ; McCown TJ; Samulski RJ; Bilaniuk LT; Wang DJ; De Vivo DC; Janson CG; Leone P
    Neurobiol Dis; 2016 Dec; 96():323-334. PubMed ID: 27717881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy.
    von Jonquieres G; Spencer ZHT; Rowlands BD; Klugmann CB; Bongers A; Harasta AE; Parley KE; Cederholm J; Teahan O; Pickford R; Delerue F; Ittner LM; Fröhlich D; McLean CA; Don AS; Schneider M; Housley GD; Rae CD; Klugmann M
    Acta Neuropathol; 2018 Jan; 135(1):95-113. PubMed ID: 29116375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by (13)C MRS and [1-(13)C]glucose infusion.
    Moreno A; Ross BD; Blüml S
    J Neurochem; 2001 Apr; 77(1):347-50. PubMed ID: 11279290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical clinical and radiological course of a patient with Canavan disease.
    Sarret C; Boespflug-Tanguy O; Rodriguez D
    Metab Brain Dis; 2016 Apr; 31(2):475-9. PubMed ID: 26586007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease.
    Assadi M; Janson C; Wang DJ; Goldfarb O; Suri N; Bilaniuk L; Leone P
    Eur J Paediatr Neurol; 2010 Jul; 14(4):354-9. PubMed ID: 20034825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative measurements with localized 1H MR spectroscopy in children with Canavan's disease.
    Wittsack HJ; Kugel H; Roth B; Heindel W
    J Magn Reson Imaging; 1996; 6(6):889-93. PubMed ID: 8956134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablating N-acetylaspartate prevents leukodystrophy in a Canavan disease model.
    Guo F; Bannerman P; Mills Ko E; Miers L; Xu J; Burns T; Li S; Freeman E; McDonough JA; Pleasure D
    Ann Neurol; 2015 May; 77(5):884-8. PubMed ID: 25712859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressing N-Acetyl-l-Aspartate Synthesis Prevents Loss of Neurons in a Murine Model of Canavan Leukodystrophy.
    Sohn J; Bannerman P; Guo F; Burns T; Miers L; Croteau C; Singhal NK; McDonough JA; Pleasure D
    J Neurosci; 2017 Jan; 37(2):413-421. PubMed ID: 28077719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of Canavan disease.
    Matalon R; Michals-Matalon K
    Eur J Paediatr Neurol; 1998; 2(2):69-76. PubMed ID: 10724099
    [No Abstract]   [Full Text] [Related]  

  • 17. [Magnetic resonance tomography and localized proton spectroscopy in 2 siblings with Canavan's disease].
    Engelbrecht V; Rassek M; Gärtner J; Kahn T; Mödder U
    Rofo; 1995 Sep; 163(3):238-44. PubMed ID: 7548871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical MRI findings in Canavan disease: a patient with a mild course.
    Yalcinkaya C; Benbir G; Salomons GS; Karaarslan E; Rolland MO; Jakobs C; van der Knaap MS
    Neuropediatrics; 2005 Oct; 36(5):336-9. PubMed ID: 16217711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Canavan disease].
    Harting I; Seitz A
    Rofo; 2001 Oct; 173(10):M275-6. PubMed ID: 11710318
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of Canavan-Van Bogaert-Bertrand leukodystrophy].
    Mikhaĭlova SV; Zakharova EIu; Bukina AM; Il'ina ES; Pokrovskaia AIa; Fedoniuk ID; Bembeeva RTs; Petrukhin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(4):50-4. PubMed ID: 15270300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.